# Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus

> **NCT01868646** · PHASE4 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 190 (actual)

## Conditions studied

- Type II Diabetes Mellitus

## Interventions

- **DRUG:** Subetta
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01868646
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-07
- **Primary completion:** 2016-06-15
- **Final completion:** 2016-06-15
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2019-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01868646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01868646, "Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01868646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*